Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Dicot logo — Dicot is a pharmaceutical company focused on increasing well...

Dicot

Dicot is a pharmaceutical company focused on increasing well-being through innovations that enhance sexual health.

Founded 2018 Sweden Sweden 7 employees Grant Total: $250.00K Health Care, Manufacturing +2

General Information

Company Name Dicot
Founded Year 2018
Location Sweden Sweden
Employees 7
Industries Health Care, Manufacturing, Pharmaceutical +1
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Dicot. To contact Dicot, visit dicot.se.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Dicot compare?

A PDF of Dicot and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Dicot soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Dicot

Dicot is a burgeoning player in the pharmaceutical industry, established in 2018 and headquartered in Sweden. Focused on enhancing sexual health, their mission is succinctly encapsulated in their slogan: "Dicot is a pharmaceutical company focused on increasing well-being through innovations that enhance sexual health."

Specializing in the treatment of erectile dysfunction and premature ejaculation, Dicot's primary product, LIB-01, is currently in the pre-clinical development stage. This highlights their commitment to addressing prevalent yet often under-discussed health issues within the Health Care and Lifestyle sectors, while leveraging their capabilities in pharmaceutical Manufacturing.

The company recently secured a kr250.00K grant investment in late June 2023 from Almi Invest, demonstrating external confidence in their innovative potential. This external support underscores Dicot's growth trajectory as they continue to develop solutions that promise to significantly improve quality of life.

Business keywords: Pharmaceuticals, Drug discovery, Biopharmaceuticals, Erectile dysfunction, Premature ejaculation, Sexual health, Lifestyle drugs, Drug development

Services & Products

Development of next-generation potency drug for treating erectile dysfunction and premature ejaculation

Target Customers

Men and couples worldwide suffering from sexual dysfunction

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant kr250.00K 1
Almi Invest
Almi Invest
29 Jun 2023

Dicot Alternatives & Competitors

View All Alternatives
Dicot vs
Hormosan Pharma GmbH
Hormosan Pharma GmbH Germany

We provide Rx pharmaceuticals to the German market, focus on sexual health, pain therapy and neurolo...

75 employees
Health Care, Pharmaceutical
Dicot vs
BioSante Pharmaceuticals
BioSante Pharmaceuticals

Pioneering advancements in female sexual health, menopause, contraception, and male hypogonadism wit...

Post-IPO Equity
Biotechnology, Health Care
Dicot vs
MODAVAR PHARMACEUTICALS LLC
MODAVAR PHARMACEUTICALS LLC United States

A global pharmaceutical company with a mission to reimagine medicines that enhance and extend the li...

22 employees
Biotechnology, Health Care
View all alternatives

FAQ About Dicot

Dicot is a pharmaceutical company focused on increasing well-being through innovations that enhance sexual health.
Dicot was founded in 2018.
Dicot is headquartered in Sweden.
Dicot operates in Health Care, Manufacturing, Pharmaceutical and Lifestyle. Its work centres on Pharmaceuticals, Drug discovery, Biopharmaceuticals and Erectile dysfunction. Its customers include Men and couples worldwide suffering from sexual dysfunction.
Dicot has approximately 7 employees.
Dicot has completed 1 funding round, raising a total of $250.00K. The latest funding stage is Grant.
Dicot offers: Development of next-generation potency drug for treating erectile dysfunction and premature ejaculation.
Top alternatives and competitors to Dicot include Hormosan Pharma GmbH, BioSante Pharmaceuticals, MODAVAR PHARMACEUTICALS LLC, ZYUS Life Sciences, Rugiet. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Dicot and Hormosan Pharma GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Dicot, https://bouncewatch.com/company/dicot, updated 10 November 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout